Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasting versus fasting plus metformin in overweight and obese children
IRCT20260707070091N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in obesity and Overweight (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Change in body mass index. Started Jul 2026; status: completed.
02
Drugs
metformin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on IRCT20260707070091N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260707070091N1.